• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    What You’re Reading in November

    Millstone Medical Outsourcing Moves Testing Services into Expanded Facility

    Nordson Medical Expands Easton, PA Operations

    RSNA23: Ricoh & Materialise Partner to Broaden Access to 3D-Printed Patient-Specific Solutions

    Spectral MD Awarded $149M BARDA Project BioShield Contract
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Qosina Corp.

    Johari Digital Healthcare Ltd.

    Medbio LLC

    BMP Medical

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA

    2023 in Review: Philips Breathes No Easier in Respiratory Recall
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    Johari Digital Healthcare Ltd.

    Medbio LLC

    BMP Medical

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves BD's Venous Stent to Treat Iliofemoral Venous Occlusive Disease

    Venovo Venous Stent proven safe and effective in iliac and femoral veins.

    FDA Approves BD
    BD-Venovo venous stent.
    PR Newswire03.14.19
    BD announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow specific to the iliac and femoral veins located near the groin.
     
    The Venovo venous stent is a flexible nitinol stent specifically designed to reopen blocked iliac and femoral veins in order to maintain adequate blood flow. The Venovo venous stent is designed with a balance of radial strength, compression resistance, and flexibility needed for the treatment of symptomatic post-thrombotic and non-thrombotic iliofemoral lesions. Additionally, the broad stent sizing allows clinicians to treat large diameter veins and long lesion lengths.
     
    "The unique attributes of the Venovo stent make it particularly well-suited to treat iliofemoral occlusive disease," said Dr. Michael Dake, University of Arizona and the principal investigator for the Venovo IDE trial. "Most importantly, it is purpose-built for application in veins, and engineered to address the special challenges of venous lesions that are very different than those posed by arterial narrowing."
     
    Iliofemoral venous occlusive disease occurs when there is impaired blood flow in the iliofemoral vein caused by acute or chronic deep-vein thrombosis, post-thrombotic syndrome, iliofemoral vein compression including May-Thurner Syndrome or a combination of these diseases.1 Symptoms include swelling of the legs, pain when standing, skin discoloration and ulcers.2 
     
    One-year results from the prospective, multicenter single-arm VERNACULAR trial involving 170 subjects demonstrated the safety and effectiveness of the Venovo venous stent for the treatment of symptomatic iliofemoral venous outflow obstruction. The clinical findings showed a weighted primary patency rate of 88.3 percent, with a 96.9 percent patency rate in non-thrombotic lesions and an 81.3 percent patency rate in post-thrombotic lesions at 12 months, exceeding the performance goal of 74 percent. In addition, patients treated with the Venovo venous stent reported a statistically significant reduction in pain symptoms and improvement in quality of life (assessed by CIVIQ-20) at 12 months from baseline. The Venovo venous stent was also deployed successfully to the target lesion and showed adequate coverage in all cases, and there were no fractures seen at 12 months.
     
    "The FDA premarket approval of the Venovo venous stent represents a significant advance for interventionalists treating iliofemoral venous occlusive disease, an underrecognized condition," said Steve Williamson, worldwide president of Peripheral Intervention at BD. "We designed the Venovo venous stent in collaboration with clinicians to enable them to treat both post-thrombotic and non-thrombotic lesions. Clinicians will now have access to the broadest range of stent sizes in the U.S. for these difficult-to-treat lesions."
     
    The Venovo venous stent is commercially available in the U.S., Europe, Argentina, Australia, Brazil, Egypt, India, Israel, Mexico, Russia, Saudi Arabia, Singapore, and Taiwan.
     
    References
    1 Foley T, et al. (2015). Iliofemoral Deep Vein Thrombosis, Available online 24 November 2015.
    2 Al-Nouri O, Milner R. May-Thurner Syndrome, Vascular Disease Management 2011; 8(3).
     
    Related Searches
    • first
    • blood
    • australia
    • stent
    Related Knowledge Center
    • Cardiovascular
    • Surgical
    Suggested For You
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    FDA Approves TransMedics FDA Approves TransMedics' OCS Heart System for Donor Hearts
    FDA Issues EUA for BD Veritor At-Home Covid-19 Test FDA Issues EUA for BD Veritor At-Home Covid-19 Test
    BD Launches FACSymphony A1 Benchtop Cell Analyzer BD Launches FACSymphony A1 Benchtop Cell Analyzer
    BD Names Christopher DelOrefice as EVP and CFO BD Names Christopher DelOrefice as EVP and CFO
    LifeSignals Inc. Receives FDA Approval for Remote Monitoring Platform LifeSignals Inc. Receives FDA Approval for Remote Monitoring Platform
    Nevro Corp Receives FDA Approval for Senza System Nevro Corp Receives FDA Approval for Senza System
    BD Acquires Velano Vascular BD Acquires Velano Vascular
    Receiving FDA Approval in Under One Month Receiving FDA Approval in Under One Month
    FDA Approves AtriCure FDA Approves AtriCure's EPi-Sense System for Persistent Afib
    Expanded FDA Approval for Medtronic Expanded FDA Approval for Medtronic's Arctic Front Cryoablation Catheter
    FDA Clears Neurescue FDA Clears Neurescue's Intelligent Balloon Catheter

    Related Breaking News

    • Diagnostics
      Babson Diagnostics Raises $31 Million in Series B Funding

      Babson Diagnostics Raises $31 Million in Series B Funding

      Money will be used to help drive commercialization of customer-first, highly accessible diagnostic blood testing.
      Business Wire 09.20.21

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Portico with FlexNav TAVR System

      Self-expanding TAVR valve features intra-annular (within the native valve) leaflets.
      PR Newswire 09.20.21

    • Medical Devices Market to Top $671.49 Billion by 2027

      Medical Devices Market to Top $671.49 Billion by 2027

      Wearables and rising cases of chronic diseases will help fuel growth, industry data predicts.
      Precedence Research 09.16.21


    • Indago Announces $10 Million Financing Close and Name Change

      Indago Announces $10 Million Financing Close and Name Change

      Lazurite Holdings is developing technology to create the operating room of the future.
      Business Wire 09.15.21

    • Cardiovascular
      FDA Approves TransMedics

      FDA Approves TransMedics' OCS Heart System for Donor Hearts

      Indicated for preservation of DBD (donors after brain death) hearts.
      PR Newswire 09.07.21

    Loading, Please Wait..

    Breaking News
    • What You’re Reading in November
    • Millstone Medical Outsourcing Moves Testing Services into Expanded Facility
    • Nordson Medical Expands Easton, PA Operations
    • RSNA23: Ricoh & Materialise Partner to Broaden Access to 3D-Printed Patient-Specific Solutions
    • Spectral MD Awarded $149M BARDA Project BioShield Contract
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ahiflower Replaces Key Tissue DHA in Mice Comparably to Marine DHA
    Chromadex’s Niagen NR Tested in Phase 1 Parkinson's Study
    Alkemist Announces New Participants in its Transparency Program
    Coatings World

    Latest Breaking News From Coatings World

    PPG Earns Equality 100 Award in 2023 Corporate Equality Index
    Beckers Aiming for New Industry Standard for Sustainability
    Birla Carbon Celebrates 65th Anniversary of Cubatão Plant in Brazil
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    What You’re Reading in November
    Millstone Medical Outsourcing Moves Testing Services into Expanded Facility
    Nordson Medical Expands Easton, PA Operations
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Intas Pharmaceuticals Receives Another Warning Letter from FDA
    Ono Expands Investment in Ono Venture Fund to $200M
    Sirnaomics Names Francois Lebel Chief Medical Officer
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Mary Kay Expands Operations into Hungary
    Anti-Aging Products Market to Hit $60 Billion by 2030
    Wella Company Marks 3 Years of Success—& Aims to Expand
    Happi

    Latest Breaking News From Happi

    Beverly Hills MD Sells Over 7.5 Million Units of Its Dermal Repair Complex
    Mary Kay Expands to Hungary
    Itching: Is a Common Skin Bacterium Behind It?
    Ink World

    Latest Breaking News From Ink World

    Pacer Print Produces High Quality Labels with Epson SurePress L-6534VW UV
    BASF Expands Certification of Recyclability of Multi-layer Films Containing Polyamide
    Mark Andy Selects Duane Pekar as CEO
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Top stories from November
    Davis-Standard's headquarters attains ISO 14001 certification
    Abbott Label named AFFLINK preferred supplier
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Optima Packaging Group Awarded for its Digitalization Strategy
    What You’re Reading on Nonwovens-Industry.com
    ISSA Clean Advocacy Summit and Fly-In Set for April
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT’s Most Read Articles in November
    Anika's Integrity Implant System Makes its O.R. Debut
    Study Shows How a Multimodal Feedback System Can Improve Laser Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Emerson Appoints Michael Tang as Chief Legal Officer
    Canatu Presents Film Heaters at DVN LiDAR
    Jabil Updates Fiscal 2024 Outlook

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login